Vimarsana
Biggest News Aggregation in the World

Hematologic Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Disorders Today - Breaking & Trending Today

CT Poses Risk for Malignant Hematopathies Among Children - Vimarsana News

CT Poses Risk for Malignant Hematopathies Among Children

Data suggest that risk increases even with low radiation doses.

Global Rare Disease Clinical Trials Market to 2030: - Vimarsana News

Global Rare Disease Clinical Trials Market to 2030:

Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area...

FDA Approves New Indication for Avapritinib - Vimarsana News

FDA Approves New Indication for Avapritinib

Avapritinib (AYVAKIT) is now approved to treat adults with indolent systemic mastocytosis.

Rare Diseases Market is projected to grow at a CAGR of - Vimarsana News

Rare Diseases Market is projected to grow at a CAGR of

As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the...

Post-Roe, Pregnant SCD Patients Facing 'Dire' Risks - Vimarsana News

Post-Roe, Pregnant SCD Patients Facing 'Dire' Risks

Women with sickle cell disease have high-risk pregnancies with significant potential for health crises and death; physicians are concerned that tighter restrictions on abortions may compromise their care.